Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 30;14(11):e246084.
doi: 10.1136/bcr-2021-246084.

Case of papillary thyroid cancer presenting with an inoperable cervical mass successfully treated with high-dose radiation therapy

Affiliations
Case Reports

Case of papillary thyroid cancer presenting with an inoperable cervical mass successfully treated with high-dose radiation therapy

Yasuo Kosugi et al. BMJ Case Rep. .

Abstract

External-beam radiation therapy (EBRT) for differentiated thyroid cancer has been controversial. Palliative irradiation is usually recommended for patients with treatment-resistant relapse and/or distant metastases, but high-dose EBRT is not often indicated in this situation. A 50-year-old man had treatment-resistant recurrence of an inoperable cervical mass and multiple lung metastases after total thyroidectomy and neck dissection. Because the patient had good performance status and no other life-threatening metastases, he received high-dose intensity-modulated radiation therapy (IMRT). Remarkably, the tumour shrank during treatment. After 3 months, he had bleeding from the internal carotid artery. The bleeding was outside the high-dose irradiation site and was likely due to infection; emergency interventional radiology was performed. The post-EBRT clinical course was favourable and the cervical mass almost disappeared. The patient remained alive for 3 years post treatment. It is possible to extend the indication of high-dose intensity-IMRT in selected patients with differentiated thyroid cancer.

Keywords: head and neck cancer; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Pretreatment images: body-surface image (A) and enhanced CT scan in coronal plane (B). Images 1 year after treatment: body-surface image (C) and enhanced CT scan in coronal plane (D).
Figure 2
Figure 2
Dose distribution of intensity-modulated radiation therapy in coronal plane (A) and axial views at laryngeal (B). (C) Dose volume histogram depicting the dosimetric parameters analysed at the central gross tumour volume (pink), marginal planning target volume (red), left carotid artery (green), trachea (yellow), spinal cord (blue) and lungs (light blue).

References

    1. Schwartz DL, Lobo MJ, Ang KK, et al. . Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 2009;74:1083–91. 10.1016/j.ijrobp.2008.09.023 - DOI - PMC - PubMed
    1. Song H-J, Qiu Z-L, Shen C-T, et al. . Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol 2015;173:399–408. 10.1530/EJE-15-0296 - DOI - PubMed
    1. Tuttle RM, Rondeau G, Lee NY. A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control 2011;18:89–95. 10.1177/107327481101800203 - DOI - PubMed
    1. Giuliani M, Brierley J. Indications for the use of external beam radiation in thyroid cancer. Curr Opin Oncol 2014;26:45–50. 10.1097/CCO.0000000000000027 - DOI - PubMed
    1. Haugen BR, Alexander EK, Bible KC, et al. . 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines Task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1–133. 10.1089/thy.2015.0020 - DOI - PMC - PubMed

Publication types